Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer

PURPOSE: Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have not been assessed. This study reports testing rates...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCO Precis Oncol
Asıl Yazarlar: Gutierrez, Martin E., Price, Kristin S., Lanman, Richard B., Nagy, Rebecca J., Shah, Irfan, Mathura, Shivam, Mulcahy, Michael, Norden, Andrew D., Goldberg, Stuart L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2019
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448804/
https://ncbi.nlm.nih.gov/pubmed/32923867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00274
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller